| Literature DB >> 28436429 |
Bo Wang1, Guoling You1, Qihua Fu1.
Abstract
Heart development is a complex process requiring dynamic transcriptional regulation. Disturbance of this process will lead to severe developmental defects such as congenital heart disease/defect (CHD). CHD is a group of complex disorder with high genetic heterogeneity, common pathways associated with CHD remains largely unknown. In the manuscript, we focused on the tissue specific genes in human fetal heart samples to explore such pathways. We used the RNA microarray dataset of human fetal tissues from ENCODE project to identify genes with heart tissue specific expression. A transcriptional network was constructed for these genes based on the Pearson correlation coefficients of their expression levels. Function, selective constraints and disease associations of these genes were then examined. Our analysis identified a network consisted of 316 genes with human fetal heart specific expression. The network was highly co-regulated and showed evolutionary conserved tissue expression pattern in tetrapod. Genes in this network are enriched in CHD specific genes and disease mutations. Using the transcriptomic data, we discovered a highly concerted gene network that might reflect a common pathway associated with the etiology of CHD. Such analysis should be helpful for disease associated gene identification in clinical studies.Entities:
Mesh:
Year: 2017 PMID: 28436429 PMCID: PMC5402266 DOI: 10.1038/srep46760
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Heatmap of expression of 316 human fetal heart specific genes.
Figure 2Heatmap of expression of 20 known CHD genes in human fetal heart specific genes.
Figure 3Co-expression network for 316 human fetal heart specific genes.
Significantly functional enriched items.
| Enrichment terms | Gene counts of heart specific genes | p-value | Benjamini |
|---|---|---|---|
| Cardiomyopathy | 28 | 2.9e-29 | 8.5e-27 |
| Z disc | 32 | 3.7e-29 | 9.3e-27 |
| Cardiac muscle contraction | 18 | 3.7e-19 | 5.5e-16 |
| Muscle protein | 19 | 1.1e-18 | 1.7e-16 |
| Muscle filament sliding | 15 | 8.2e-16 | 5.8e-13 |
| Cardiac muscle contraction | 18 | 8.4e-15 | 1.5e-12 |
| Sarcomere | 14 | 2.1e-14 | 2.6e-12 |
| Ventricular cardiac muscle tissue morphogenesis | 11 | 4.6e-12 | 2.3e-9 |
| Actin binding | 26 | 5.4e-12 | 2.7e-9 |
| Heart development | 21 | 4.5e-11 | 1.7e-8 |
| Structural constituent of muscle | 12 | 5.2e-11 | 1.3e-8 |
| Adrenergic signaling in cardiomyocytes | 19 | 7.5e-11 | 6.8e-9 |
| Actin-binding | 23 | 2.5e-10 | 2.4e-8 |
| Muscle contraction | 16 | 3.8e-10 | 1.1e-7 |
| Regulation of the force of heart contraction | 9 | 4.1e-10 | 1.0e-7 |
| Sarcomere organization | 10 | 7.9e-10 | 1.7e-7 |
| Regulation of heart rate | 10 | 2.9e-9 | 5.3e-7 |
| Actin cytoskeleton | 19 | 1.6e-8 | 1.3e-6 |
| Disease mutation | 75 | 2.3e-8 | 1.7e-6 |
| Dilated cardiomyopathy | 13 | 2.5e-8 | 1.5e-6 |
Figure 4Heatmap of relationship of human fetal heart specific genes with significantly enriched functional items.
Figure 5Comparison of the average derived allele frequency for the 316 human fetal heart specific genes and all protein coding genes.
Figure 6Tissue specification of the 316 gene orthologs in 10 tetrapod.
The numbers of genes that have corresponding orthologs for each species are labeled on the branches.